Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OCTRU joined members of the NPEU and the Thames Valley and South Midlands Clinical Research Network today to mark International Clinical Trials Day.

It is nearly 250 years since James Lind ran the first clinical trial on 12 sailors to work out how to treat scurvy and save lives.  Today things have moved on a bit, and the 20th May is designated as International Clinical Trials Day.  

 

Staff from OCTRU joined up with staff from the National Perinatal and Epidemiology Unit and the Thames Valley & South Midlands Clinical Research Network to promote the NIHR campaign -  "Ok to Ask!" across the hospitals in Oxfordshire.

 

Staff were on hand to highlight the 6 clinical trial units located in Oxford and the opportunities to join clinical trials across the country either as a patient or as a healthy volunteer.

 

Staff in SITU - the Surgical Intervention Trials Unit, a part of OCTRU also took to twitter today to highlight the reasons they undertake research  https://twitter.com/SITU_Oxford 

Similar stories

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.